Enhanced pyridoxal 5′-phosphate synthetic enzyme immunoreactivities do not contribute to GABAergic inhibition in the rat hippocampus following pilocarpine-induced status epilepticus

Neuroscience

Volumn 159, Issue 3, 2009, Pages 1108-1118

  Kwak, S E ^a   Kim, J E ^a   Kim, D W ^a   Kwon, O S ^b   Choi, S Y ^a   Kang, T C ^a  

^a Hallym University   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

epilepsy; excitability; paired pulse inhibition; pyridoxal kinase; pyridoxine 5 phosphate oxidase

Indexed keywords

PILOCARPINE; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL 5' PHOSPHATE OXIDASE; PYRIDOXAL KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CONTROLLED STUDY; DENTATE GYRUS; EPILEPTIC STATE; GABAERGIC TRANSMISSION; GRANULE CELL; HIPPOCAMPUS; IMMUNOREACTIVITY; INHIBITION KINETICS; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; UPREGULATION;

ACTION POTENTIALS; ANIMALS; CELL DEATH; DENTATE GYRUS; GAMMA-AMINOBUTYRIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; LINEAR MODELS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NEURAL INHIBITION; PILOCARPINE; PYRAMIDAL CELLS; PYRIDOXAL KINASE; PYRIDOXAMINEPHOSPHATE OXIDASE; RATS; RATS, SPRAGUE-DAWLEY; STATUS EPILEPTICUS; TIME FACTORS;

EID: 62249185960     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.01.046     Document Type: Article

References (56)

1. An S.J., Park S.K., Hwang I.K., Choi S.Y., Kwon O.S., Won M.H., and Kang T.C. Vigabatrin inhibits pyridoxine-5′-phosphate oxidase, not pyridoxal kinase in the hippocampus of seizure prone gerbils. Neurochem Int 44 (2004) 133-137
2. Andersen P., Holmqvist B., and Voorhoeve P.E. Excitatory synapses on hippocampal apical dendrites activated by entorhinal stimulation. Acta Physiol Scand 66 (1966) 461-472
3. Bahn J.H., Kwon O.S., Joo H.M., Jang S.H., Park J., Hwang I.K., Kang T.C., Won M.H., Kwon H.Y., Kwok F., Kim H.B., Cho S.W., and Choi S.Y. Production of monoclonal antibodies and immunohistochemical studies of brain pyridoxine-5′-phosphate oxidase. Brain Res 925 (2002) 159-168
4. Barnard E.A., Bilbe G., Houamed K., Moss S.J., Van Renterghem C., and Smart T.G. Functional expression in the Xenopus oocyte of messenger ribonucleic acids encoding brain neurotransmitter receptors: further characterisation of the implanted GABA receptor. Neuropharmacology 26 (1987) 837-844
5. Bekenstein J.W., and Lothman E.W. Dormancy of inhibitory interneurons in a model of temporal lobe epilepsy. Science 259 (1993) 97-100
6. A receptor subunit expression and function in temporal lobe epilepsy. Nat Med 4 (1998) 1166-1172
7. Buckmaster P.S., Tam E., and Schwartzkroin P.A. Electrophysiological correlates of seizure sensitivity in the dentate gyrus of epileptic juvenile and adult gerbils. J Neurophysiol 76 (1996) 2169-2180
8. Buhl E.H., Otis T.S., and Mody I. Zinc-induced collapse of augmented inhibition by GABA in a temporal lobe epilepsy model. Science 271 (1996) 369-373
9. Choi J.D., Bowers-Komro M., Davis D.M., Edmondson D.E., and McCormick D.B. Kinetic properties of pyridoxamine (pyridoxine)-5′-phosphate oxidase from rabbit liver. J Biol Chem 258 (1983) 840-845
10. A receptors in epileptic hippocampus: enhanced synaptic efficacy and altered pharmacology. Eur J Neurosci 17 (2003) 1607-1616
11. Combeau C., and Carlier M.F. Covalent modification of G-actin by pyridoxal 5′-phosphate: polymerization properties and interaction with DNase I and myosin subfragment 1. Biochemistry 31 (1992) 300-309
12. de Lanerolle N.C., Kim J.H., Robbins R.J., and Spencer D.D. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res 495 (1989) 387-395
13. Doherty J., and Dingledine R. Reduced excitatory drive onto interneurons in the dentate gyrus after status epilepticus. J Neurosci 21 (2001) 2048-2057
14. Ebadi M., Bifano J., Klangkalya B., Govitrapong P., and Durham P. Levodopa-mediated alteration in the activity of pyridoxal kinase in rat basal ganglia. Pharmacology 17 (1978) 149-156
15. Erlander M.G., Tillakaratne N.J., Feldblum S., Patel N., and Tobin A.J. Two genes encode distinct glutamate decarboxylases. Neuron 7 (1991) 91-100
16. Erlander M.G., and Tobin A.J. The structural and functional heterogeneity of glutamic acid decarboxylase: a review. Neurochem Res 16 (1991) 215-226
17. Esclapez M., and Houser C.R. Upregulation of GAD65 and GAD67 in remaining hippocampal GABA neurons in a model of temporal lobe epilepsy. J Comp Neurol 412 (1999) 488-505
18. Foster T.C., and McNaughton B.L. Long-term enhancement of CA1 synaptic transmission is due to increased quantal size, not quantal content. Hippocampus 1 (1991) 79-91
19. Fukuda T., Aika Y., Heizmann C.W., and Kosaka T. GABAergic axon terminals at perisomatic and dendritic inhibitory sites show different immunoreactivities against two GAD isoforms, GAD67 and GAD65, in the mouse hippocampus: a digitized quantitative analysis. J Comp Neurol 395 (1998) 177-194
20. Furukawa K., Fu W., Li Y., Witke W., Kwiatkowski D.J., and Mattson M.P. The actin-severing protein gelsolin modulates calcium channels and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J Neurosci 17 (1997) 8178-8186
21. i. Exp Neurol 133 (1995) 153-163
22. Glenn G.M., Krober M.S., Kelly P., McCarty J., and Weir M. Pyridoxine as therapy in theophylline-induced seizures. Vet Hum Toxicol 37 (1995) 342-345
23. Gospe Jr. S.M., Olin K.L., and Keen C.L. Reduced GABA synthesis in pyridoxine-dependent seizures. Lancet 343 (1994) 1133-1134
24. Harvey B.D., and Sloviter R.S. Hippocampal granule cell activity and c-Fos expression during spontaneous seizures in awake, chronically epileptic, pilocarpine-treated rats: implications for hippocampal epileptogenesis. J Comp Neurol 488 (2005) 442-463
25. Houser C.R., and Esclapez M. Localization of mRNAs encoding two forms of glutamic acid decarboxylase in the rat hippocampal formation. Hippocampus 4 (1994) 530-545
26. Hwang I.K., Yoo K.Y., Kimdo H., Lee B.H., Kwon Y.G., and Won M.H. Time course of changes in pyridoxal 5′-phosphate (vitamin B6 active form) and its neuroprotection in experimental ischemic damage. Exp Neurol 206 (2007) 114-125
27. Hwang I.K., Yoo K.Y., Kim D.S., Eum W.S., Park J.K., Park J., Kwon O.S., Kang T.C., Choi S.Y., and Won M.H. Changes of pyridoxal kinase expression and activity in the gerbil hippocampus following transient forebrain ischemia. Neuroscience 128 (2004) 511-518
28. A receptor with a high dose of pyridoxal phosphate induces tonic-clonic convulsion in immature mice. Neurochem Int 26 (1995) 369-373
29. A receptor-mediated inhibition by postsynaptic calcium in epileptic hippocampal neurons. Brain Res 810 (1998) 241-250
30. Isokawa M. Remodeling dendritic spines of dentate granule cells in temporal lobe epilepsy patients and the rat pilocarpine model. Epilepsia 41 (2000) 14-17
31. Kang T.C., Kim D.S., Kwak S.E., Kim J.E., Won M.H., Kim D.W., Choi S.Y., and Kwon O.S. Epileptogenic roles of astroglial death and regeneration in the dentate gyrus of experimental temporal lobe epilepsy. Glia 54 (2006) 258-271
32. Kang T.C., Park S.K., Hwang I.K., An S.J., Bahn J.H., Kim D.W., Choi S.Y., Kwon O.S., Baek N.I., Lee H.Y., and Won M.H. Changes in pyridoxal kinase immunoreactivity in the gerbil hippocampus following spontaneous seizure. Brain Res 957 (2002) 42-50
33. Kang T.C., Park S.K., Hwang I.K., An S.J., Bahn J.H., Kim A.Y., Choi S.Y., Kwon O.S., Baek N.I., Lee H.Y., and Won M.H. Chronological changes in pyridoxine-5′-phosphate oxidase immunoreactivity in the seizure-sensitive gerbil hippocampus. J Neurosci Res 68 (2002) 785-791
34. Kim J.E., Kim D.W., Kwak S.E., Kwon O.S., Choi S.Y., and Kang T.C. Potential role of pyridoxal-5′-phosphate phosphatase/chronopin in epilepsy. Exp Neurol 211 (2008) 128-140
35. Klugmann M., Leichtlein C.B., Symes C.W., Klaussner B.C., Brooks A.I., Young D., and During M.J. A novel role of circadian transcription factor DBP in hippocampal plasticity. Mol Cell Neurosci 31 (2006) 303-314
36. Kobayashi M., and Buckmaster P.S. Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J Neurosci 23 (2003) 2440-2452
37. Kouyoumdjian J.C., and Ebadi M. Anticonvulsant activity of muscimol and gamma-aminobutyric acid against pyridoxal phosphate-induced epileptic seizures. J Neurochem 36 (1981) 251-257
38. Kwak S.E., Kim J.E., Kim D.W., Kwon O.S., Choi S.Y., and Kang T.C. Pyridoxine 5′-phosphate oxidase, not pyridoxal kinase, involves in long-term potentiation induction in the rat dentate gyrus. Hippocampus 19 (2008) 45-56
39. Kwak S.E., Kim J.E., Kim D.S., Won M.H., Lee H.J., Choi S.Y., Kwon O.S., Kim J.S., and Kang T.C. Differential paired-pulse responses between the CA1 region and the dentate gyrus are related to altered CLC-2 immunoreactivity in the pilocarpine-induced rat epilepsy model. Brain Res 1115 (2006) 162-168
40. Malinow R., and Malenka R.C. AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 25 (2002) 103-126
41. Meisler N.T., and Thanassi J.W. Pyridoxine kinase, pyridoxine phosphate phosphatase and pyridoxine phosphate oxidase activities in control and B-6-deficient rat liver and brain. J Nutr 110 (1980) 1965-1975
42. Mulligan J.H., and Snell E.E. Transport and metabolism of vitamin B6 in Salmonella typhimurium LT2. J Biol Chem 251 (1976) 1052-1056
43. Obenaus A., Esclapez M., and Houser C.R. Loss of glutamate decarboxylase mRNA-containing neurons in the rat dentate gyrus following pilocarpine-induced seizures. J Neurosci 13 (1993) 4470-4485
44. Ostroff L.E., Fiala J.C., Allwardt B., and Harris K.M. Polyribosomes redistribute from dendritic shafts into spines with enlarged synapses during LTP in developing rat hippocampal slices. Neuron 35 (2002) 535-545
45. Ouyang Y., Wong M., Capani F., Rensing N., Lee C.S., Liu Q., Neusch C., Martone M.E., Wu J.Y., Yamada K., Ellisman M.H., and Choi D.W. Transient decrease in F-actin may be necessary for translocation of proteins into dendritic spines. Eur J Neurosci 22 (2005) 2995-3005
46. Racine R. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32 (1972) 281-284
47. Salazar P., and Tapia R. Seizures induced by intracerebral administration of pyridoxal-5′-phosphate: effect of GABAergic drugs and glutamate receptor antagonists. Neuropharmacology 41 (2001) 546-553
48. Sierra-Paredes G., Oreiro-Garcia T., Nunez-Rodriguesz A., Vazquez-Lopez A., and Sierra-Marcuno G. Seizures induced by in vivo latrunculin a and jasplakinolide microperfusion in the rat hippocampus. J Mol Neurosci 28 (2006) 151-160
49. Sloviter R.S. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 235 (1987) 73-76
50. Sloviter R.S. Feedforward and feedback inhibition of hippocampal principal cell activity evoked by perforant path stimulation: GABA-mediated mechanisms that regulate excitability in vivo. Hippocampus 1 (1991) 31-40
51. Spector R., and Greenwald L.L. Transport and metabolism of vitamin B6 in rabbit brain and choroid plexus. J Biol Chem 253 (1978) 2373-2379
52. Steward O., and Schuman E.M. Protein synthesis at synaptic sites on dendrites. Annu Rev Neurosci 24 (2001) 299-325
53. Swann J.W., Al-Noori S., Jiang M., and Lee C.L. Spine loss and other dendritic abnormalities in epilepsy. Hippocampus 10 (2000) 617-625
54. Tuff L.P., Racine R.J., and Adamec R. The effects of kindling on GABA-mediated inhibition in the dentate gyrus of the rat. I. Paired-pulse depression. Brain Res 277 (1983) 79-90
55. Waymire K.G., Mahuren J.D., Jaje J.M., Guilarte T.R., Coburn S.P., and MacGregor G.R. Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat Genet 11 (1995) 45-51
56. Wu K., and Leung L.S. Increased dendritic excitability in hippocampal CA1 in vivo in the kainic acid model of temporal lobe epilepsy: a study using current source density analysis. Neuroscience 116 (2003) 599-616